+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acromegaly Treatment Market by Treatment Type (Combination Therapies, Dopamine Agonists, Growth Hormone Receptor Antagonists), Route Of Administration (Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Acromegaly Treatment Market by Treatment Type (Combination Therapies, Dopamine Agonists, Growth Hormone Receptor Antagonists), Route Of Administration (Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Acromegaly Treatment Market by Treatment Type (Combination Therapies, Dopamine Agonists, Growth Hormone Receptor Antagonists), Route Of Administration (Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715655
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The acromegaly treatment market is undergoing significant transformation, driven by advancements in therapeutic approaches, technology, and shifting regulatory frameworks. Senior healthcare decision-makers will find a rapidly evolving landscape where innovation, precision, and patient-centric strategies define competitive advantage.

Market Snapshot: Acromegaly Treatment Market Outlook

The Acromegaly Treatment Market grew from USD 2.72 billion in 2024 to USD 3.00 billion in 2025. It is expected to continue growing at a CAGR of 9.95%, reaching USD 4.81 billion by 2030. With this resilient growth trajectory, stakeholders are presented with expanding opportunities for investment, product innovation, and regional market development that address critical unmet needs in global acromegaly care.

Scope & Segmentation

This research delivers a comprehensive evaluation of the acromegaly treatment market with a multi-layered segmentation, enabling decision-makers to target high-value opportunities with actionable insights. The key segments under analysis include:

  • Treatment Types: Combination therapies, dopamine agonists, growth hormone receptor antagonists, radiotherapy, somatostatin analogs, surgical interventions.
  • Combination Therapy Modalities: Dopamine agonist combinations, pegvisomant combinations, somatostatin analog combinations.
  • Dopamine Agonists: Bromocriptine, cabergoline.
  • Growth Hormone Receptor Antagonists: Pegvisomant.
  • Radiotherapy Modalities: Conventional radiotherapy, proton therapy, stereotactic radiotherapy.
  • Somatostatin Analogs: Long acting injectables, oral analogs, short acting injectables.
  • Surgical Approaches: Craniotomy, endoscopic transsphenoidal surgery, microscopic transsphenoidal surgery.
  • Routes of Administration: Injectable (intramuscular, subcutaneous), oral.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • End Users: Homecare, hospitals, specialty clinics.
  • Geographies Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East and Africa (including United Kingdom, Germany, France, Russia, Saudi Arabia, and others), Asia-Pacific (China, India, Japan, Australia, and additional key markets).
  • Featured Companies: Ipsen S.A., Novartis AG, Pfizer Inc., Chiasma, Inc., Recordati S.p.A.

Key Takeaways for Senior Decision-Makers

  • Therapeutic innovation is reshaping care delivery, with the emergence of oral analogs and sustained-release injectables driving patient convenience and treatment adherence.
  • Segment specificity is critical as nuanced differences in administration routes, formulation types, and settings of care align with evolving clinical guidelines and user preferences.
  • Regional market variations influence adoption, with established reimbursement practices and evidence-generation frameworks propelling uptake in developed economies and cost-driven choices shaping emerging markets.
  • Collaborative models across specialties—linking endocrinologists, neurosurgeons, and pharmacologists—are essential for optimizing long-term outcomes and responding to patient heterogeneity.
  • Strategic alliances between biopharmaceutical innovators, contract organizations, and digital solution partners support accelerated development cycles and real-time monitoring capabilities.
  • Investments in regional manufacturing and supply chain agility are increasingly relevant amid external shocks and evolving tariff regimes.

Tariff Impact: Navigating 2025 Regulatory Changes

Revised United States tariff schedules in 2025 have introduced new complexities into acromegaly treatment market dynamics. Higher import duties on biopharma ingredients and specialized devices are driving reevaluation of sourcing strategies, supporting the growth of local production and alternative procurement channels. These changes reverberate across distribution partners, inventory management practices, and pricing strategies—all of which influence downstream treatment accessibility and necessitate agile, evidence-driven responses from industry leaders.

Methodology & Data Sources

This report is built on a multimodal research design comprising systematic reviews of peer-reviewed publications, clinical trial databases, regulatory filings, and real world data repositories. Data triangulation is used to validate major trends, and insights from structured interviews with clinicians, pharmacists, and payers inform qualitative and quantitative analysis throughout.

Why This Report Matters

  • Supports decision-making with robust segmentation and in-depth analysis of market drivers, barriers, and technological trends.
  • Equips leadership teams to capitalize on changing regulatory and reimbursement frameworks with actionable, evidence-based recommendations.
  • Enables identification of targeted opportunities for expansion, innovation, and operational optimization across global and regional markets.

Conclusion

The acromegaly treatment market is advancing through a synthesis of precision therapeutics, next-generation technologies, and collaborative care models. Strategic insights provided here empower stakeholders to adapt seamlessly, unlocking value across the evolving therapeutics landscape and ensuring sustained progress in patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in oral somatostatin analogues improving patient adherence and quality of life
5.2. Development of novel oral growth hormone receptor antagonists targeting efficacy and tolerability improvements
5.3. Emergence of long-acting injectable formulations reducing dosing frequency and healthcare burdens
5.4. Growth of personalized medicine strategies through genetic profiling of pituitary adenomas
5.5. Rising investments in peptide-based therapies and innovative drug delivery platforms
5.6. Increasing adoption of telemedicine and remote monitoring for acromegaly treatment optimization
5.7. Implementation of real-world evidence studies to evaluate long-term safety and economic outcomes
5.8. Focus on patient-reported outcome measures and health-related quality of life in clinical trials
5.9. Regulatory approvals of combination therapies addressing multiple acromegaly pathophysiological pathways
5.10. Expansion of emerging market access programs for cost-effective acromegaly treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Acromegaly Treatment Market, by Treatment Type
8.1. Introduction
8.2. Combination Therapies
8.2.1. Dopamine Agonist Combinations
8.2.2. Pegvisomant Combinations
8.2.3. Somatostatin Analog Combinations
8.3. Dopamine Agonists
8.3.1. Bromocriptine
8.3.2. Cabergoline
8.4. Growth Hormone Receptor Antagonists
8.4.1. Pegvisomant
8.5. Radiotherapy
8.5.1. Conventional Radiotherapy
8.5.2. Proton Therapy
8.5.3. Stereotactic Radiotherapy
8.6. Somatostatin Analogs
8.6.1. Long Acting Injectables
8.6.2. Oral Analogs
8.6.3. Short Acting Injectables
8.7. Surgical
8.7.1. Craniotomy
8.7.2. Endoscopic Transsphenoidal Surgery
8.7.3. Microscopic Transsphenoidal Surgery
9. Acromegaly Treatment Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Subcutaneous
9.3. Oral
10. Acromegaly Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Acromegaly Treatment Market, by End User
11.1. Introduction
11.2. Homecare
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Acromegaly Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Acromegaly Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Acromegaly Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ipsen S.A.
15.3.2. Novartis AG
15.3.3. Pfizer Inc.
15.3.4. Chiasma, Inc.
15.3.5. Recordati S.p.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ACROMEGALY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ACROMEGALY TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ACROMEGALY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ACROMEGALY TREATMENT MARKET: RESEARCHAI
FIGURE 24. ACROMEGALY TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. ACROMEGALY TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. ACROMEGALY TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACROMEGALY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONIST COMBINATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONIST COMBINATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY PEGVISOMANT COMBINATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY PEGVISOMANT COMBINATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOG COMBINATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOG COMBINATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY BROMOCRIPTINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY BROMOCRIPTINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY CABERGOLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY CABERGOLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY PEGVISOMANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY PEGVISOMANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY CONVENTIONAL RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY CONVENTIONAL RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY PROTON THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY LONG ACTING INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY LONG ACTING INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ORAL ANALOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ORAL ANALOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SHORT ACTING INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SHORT ACTING INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY CRANIOTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ENDOSCOPIC TRANSSPHENOIDAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ENDOSCOPIC TRANSSPHENOIDAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY MICROSCOPIC TRANSSPHENOIDAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY MICROSCOPIC TRANSSPHENOIDAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 144. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 145. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 146. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 147. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 148. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 149. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 150. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 151. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 152. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 153. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 154. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 155. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 158. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 159. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 293. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 314. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 315. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ACROMEGALY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA ACROMEGALY TREATMENT MARKET SIZE, BY TREAT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Acromegaly Treatment market report include:
  • Ipsen S.A.
  • Novartis AG
  • Pfizer Inc.
  • Chiasma, Inc.
  • Recordati S.p.A.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.81 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Acromegaly Treatment Market Size, Share & Trends Analysis Report By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists), By Distribution Channel (Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Acromegaly Treatment Market Size, Share & Trends Analysis Report By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists), By Distribution Channel (Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Acromegaly Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Acromegaly Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Acromegaly Treatment - Global Strategic Business Report - Product Image

Acromegaly Treatment - Global Strategic Business Report

  • Report
  • 297 Pages
  • Global
From
Acromegaly Market Report 2025 - Product Image

Acromegaly Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Acromegaly Market - A Global and Regional Analysis: Focus on Drug Class, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Acromegaly Market - A Global and Regional Analysis: Focus on Drug Class, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.